ArticleJournal of ginseng research2025
Effects of red ginseng extract and red ginseng dietary fiber on the maintenance of intestinal immune and functional homeostasis in diet-induced obese mice.
Article in Journal of ginseng research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Analysis of the Effect of Autoclaving on the Flavor of Fresh Ginseng Using Electronic Nose, HS-GC-IMS, and HS-SPME-GC-MS.Foods (Basel, Switzerland) · 2026Article
- Emerging and underexplored ginsenosides in cancer therapy (2020-2025): Beyond cytotoxic mechanisms.Journal of ginseng research · 2026Review
- The roles of ginseng and ginsenosides for immune regulation: Relation to immunometabolic responses.Journal of ginseng research · 2026Review
- Ginsenosides fromJournal of ginseng research · 2026Review
- A review of pharmacological properties and pharmacokinetic of 20(S)-protopanaxadiol.Journal of ginseng research · 2026Review
- Article
- Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control.Advances in nutrition (Bethesda, Md.) · 2026Review
- Functional Ingredients: From Molecule to Market-AI-Enabled Design, Bioavailability, Consumer Impact, and Clinical Evidence.Foods (Basel, Switzerland) · 2025Review
- Modulation of Gut Microbiota by Red Ginseng Extract Powder and Dietary Fiber in Obese Mice: Identification of Key Microbial Candidates.Journal of microbiology and biotechnology · 2025Article
- Characterization of the gut microbiome in Wuhuang pigs and their crossbred offspring.Frontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is an important risk factor of intestinal inflammatory disease. This study aimed to evaluate the effects of Red ginseng extract powder (RGEP) and Red ginseng dietary fiber (RGDF) on the maintenance of immune and functional homeostasis in recovering obesity-induced impairment of intestinal immunity. Methods: Diet-induced obesity in C57BL/6 male mice was achieved by feeding them a 60 % high-fat diet for six weeks. The diet-induced obese (DIO) mice were administered RGEP (205, 410, or 820 mg/kg), fructooligosaccharide (FOS, 820 mg/kg), or RGDF (410, 820, or 1640 mg/kg) once daily for 4-8 weeks. The effects of RGEP or RGDF administration were evaluated via stool trait and gastrointestinal (GI) motility, inflammatory biomarkers and cytokines in mesenteric lymph nodes and intestine, mucosal protective genes, bacterial toxicity, and histopathological features of the intestines. Results: RGEP or RGDF administration to the DIO mice reduced mucosal barrier damaging factor (α1-antitrypsin), inflammatory cytokine levels, factors related to inflammatory responses (C-reactive protein (CRP), iNOS, NF-κB, MPO, and Calprotectin), and levels of urinary indican and intestinal β-glucuronidase. Conversely, RGEP or RGDF administration increased intestinal motility, levels of short-chain fatty acids (SCFAs) and β-defensin-2, and mucus barrier functional factor (MUC2) expression. Histopathological features of the small intestine recovered to normal levels after RGEP or RGDF administration. Conclusion: Our results demonstrated that RGEP and RGDF were effective for maintaining intestinal immune and functional homeostasis by recovering impaired immune and barrier function in DIO mice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.